Belinostat (PXD101)

Belinostat, also known as PXD101, is a novel and potent hydroxamate-type HDAC inhibitor.

Product Specifications

Background

Belinostat has been found to significantly increase the acetylation of histones H3 and H4 and exerts cytotoxicity in a wide range of tumor cell lines.

CAS Number

414864-00-9

Purity

≥ 98% by HPLC

Solubility

Soluble in DMSO

Molecular Formula

C15H14N2O4S

Shipping Conditions

Room Temperature (continental US) or Gel Packs

Storage Conditions

Store at or below –20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.